Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
2021 · Drug Safety · 78 citations
https://doi.org/10.1007/s40264-021-01086-8
A
Annamaria Mascolo
Regione Campania(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
91
Papers
1.7K
Citations
26
h-index
46
i10-index
Annamaria Mascolo is an academic researcher from Regione Campania. The author has contributed to research in topics: Diabetes Treatment and Management & Pharmacovigilance and Adverse Drug Reactions & Drug-Induced Adverse Reactions. The author has an h-index of 26, co-authored 78 publications.
ORCID: 0000-0003-2554-0065Papers by this author
worksDirect-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
2019 · Scientific Reports · 43 citations
https://doi.org/10.1038/s41598-019-43715-4
Therapeutic strategies to fight COVID‐19: Which is the <i>status artis</i>?
2021 · British Journal of Pharmacology · 41 citations
https://doi.org/10.1111/bph.15452
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study
2022 · Frontiers in Immunology · 23 citations
https://doi.org/10.3389/fimmu.2022.965171
Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature
2023 · Journal of Infection and Public Health · 11 citations
https://doi.org/10.1016/j.jiph.2023.01.009
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?
2023 · Biomedicine & Pharmacotherapy · 7 citations
https://doi.org/10.1016/j.biopha.2023.114912
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat